Bilateral upper extremity thrombophlebitis related to intravenous amiodarone: A case report

Southern Medical Journal

Volumn 98, Issue 8, 2005, Pages 814-816

  Aljitawi, Omar ^a,b   Shabaneh, Baha ^a   Whitaker, Jack ^a  

^a East Tennessee State University   (United States)

^b NONE   (United States)

Author keywords

Amiodarone; Side effect; Superficial thrombophlebitis

Indexed keywords

AMIODARONE; ANALGESIC AGENT; DICLOXACILLIN; FIBRINOLYTIC AGENT; SOTALOL;

ADULT; ANGIOPLASTY; ARTICLE; CASE REPORT; FIBRINOLYSIS; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MALE; THROMBOPHLEBITIS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARM; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; THROMBOPHLEBITIS;

EID: 24144489705     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000157556.52105.FB     Document Type: Article

References (5)

1. Aravanis C, Papasteriades E, Steriotis J. Acute thrombophlebitis due to IV use of amiodarone. Chest 1982;82:515-516.
2. Antonelli D, Barzilay J. Acute thrombophlebitis following IV amiodarone administration. Chest 1983;84:120.
3. Kreiss Y, Sidi Y, Gur H. Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department. Postgrad Med J 1999;75:278-281.
4. Joseph AP, Ward MR. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation. Ann Emerg Med 2000;36:1-9.
5. Solomon AJ, Greenberg MD, Kilborn MJ, et al. Amiodarone versus a B-blocker to prevent atrial fibrillation after cardiovascular surgery. Am Heart J 2001;142:811-815.